From September 11-12, 2025, the EMOL Health Leadership team, joined by Carlton Sedberry, DPh, attended the ICOP/Sargon Annual Summit at the Pro Football Hall of Fame in Canton, Ohio.
EMOL Health founder, Brian Decker participated in a panel discussion entitled; Using Real-Time Data to Drive Enrollment and Performance- focusing on how sites are leveraging dashboards, EMR tools, and AI. This panel discussed how clinical trial sites are increasingly using real-time dashboards, EMR tools, and AI to enhance enrollment and performance. Brian emphasized that dashboards provide site leaders with instant visibility into key metrics, allowing teams to track patient enrollment, monitor performance, and quickly identify areas for improvement. By integrating these tools, sites can automate data collection and reporting, reducing manual effort, and improving data accuracy. The panel highlighted that embracing these technologies not only streamlines workflows but also positions sites to respond rapidly to changing conditions and deliver better results for sponsors and patients.
At the Summit, Carlton Sedberry, DPh, introduced EMOL partner, ImmunoBridge, emphasizing the company’s commitment to making advanced CAR-T therapies accessible to community oncology centers. ImmunoBridge was founded on the belief that access to life-saving immunotherapies like CAR-T shouldn’t be limited by location or resources. By partnering directly with community oncologists, ImmunoBridge helps remove the complexities and barriers that often prevent smaller practices from offering these innovative treatments. As the first independent, full-service CAR-T center, ImmunoBridge has developed a unique model that streamlines therapy administration, patient monitoring, and reimbursement processes—allowing oncologists to focus on patient care while ensuring that cutting-edge treatments are available close to home.
